×

BioCorRx, Inc. Announces 111% Increase in Patients Treated with Start Fresh Program and Upcoming Shareholder Conference Call

Los Angeles, Sept. 17, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), a leader in addiction treatment, announces a 111% increase in patients being treated with its Start Fresh Program since July 2014 by independent clinics. The Company believes the increase is due to significant national expansion and branding efforts over the course of the year to date. In 2014 BioCorRx, Inc. secured license agreements for ten additional states and direct distribution deals with clinics in two other states owned by Dr. George Fallieras. Currently, there are nine clinics open serving patients using the Start Fresh Program, compared to just one operating clinic this time last year. By year-end, at least three new clinics should be opening according to information provided to the company by licensees and Dr. Fallieras. "We are pleased to see an increase of this magnitude, this is not only impactful for the financials of BioCorRx, Inc. but also for the families receiving the effective help they need to get them on the road to recovery" stated CEO Kent Emry.

News of the increase in patients seeking the Start Fresh Program comes at a poignant time as this September marks the 25th annual National Recovery Month by Substance Abuse and Mental Health Services Administration (SAMHSA). The focus of Recovery Month is to positively promote prevention, treatment and recovery of mental and substance use disorders. "BioCorRx, Inc. is proud to be an integral part of the community assisting families with recovery from addiction. We agree wholeheartedly with SAMHSA's stance that treatment is effective and people do recover" says Emry.

Upcoming Shareholder Conference Call

BioCorRx will host its first shareholder conference call on Wednesday, October 15, 2014, at 11:00 am Pacific Standard Time to discuss its operations for year to date and outlook for the remainder of this year and 2015. Call in details will be provided at a later date via a follow up press release, but interested parties can assure they won't miss the call in details by visiting http://bicxcorp.com/get-updates/ to request updates.

Click here to view Recent National Television Media on the BioCorRx YouTube Channel

Click here for company Facebook page for more stories and media coverage

About BioCorRx, Inc.

BioCorRx, Inc. (OTCQB: BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX, visit www.BioCorRx.com

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

CONTACT: Investor Relations SmallCapVoice.com, Inc. 512-267-2430

Source:BioCorRx